15.6
Many pathogenic bacteria produce molecules called virulence factors that help them infect host tissues.
One important group of virulence factors is extracellular enzymes.
For example, Neisseria gonorrhoeae produces IgA proteases.
These enzymes cleave secretory immunoglobulin A on mucosal surfaces, allowing bacteria to adhere to and colonize epithelial cells more effectively.
Streptococcus pyogenes produces hyaluronidase, which breaks down hyaluronic acid in the extracellular matrix.
This loosens the tissue structure, allowing bacteria to spread into deeper tissue layers.
Staphylococcus aureus produces coagulase, an enzyme that converts fibrinogen into fibrin, triggering clot formation around the bacteria. This fibrin barrier conceals bacteria from host immune cells.
S. aureus also produces kinases, such as staphylokinase, which activate host plasminogen to form plasmin. This promotes clot breakdown, allowing the bacteria to spread further in the host.
Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.
Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete enzymes that degrade components of the host’s extracellular matrix, promoting deeper tissue invasion. Streptococcus pyogenes secretes hyaluronidase, which hydrolyzes hyaluronic acid—a key constituent of the connective tissue matrix. This degradation weakens intercellular cohesion and allows bacterial dissemination. Similarly, Clostridium perfringens releases collagenase to break down collagen fibers, compromising tissue integrity and accelerating the spread through muscle and connective tissues.
Enzymatic Strategies for Immune Evasion: Bacteria counteract host defenses through enzyme-mediated immune evasion. Neisseria gonorrhoeae produces immunoglobulin A1 (IgA1) proteases that specifically cleave secretory IgA on mucosal surfaces. This cleavage prevents the antibody from neutralizing and eliminating the pathogen, facilitating bacterial adherence to and colonization of epithelial cells.
Manipulation of Host Clotting Systems: Some bacteria manipulate host coagulation pathways to their advantage. Staphylococcus aureus employs coagulase to convert fibrinogen into fibrin, forming protective fibrin clots around bacterial cells. This encapsulation shields them from phagocytosis and other immune responses. Whereas other pathogens secrete kinases such as streptokinase, which activate plasminogen to form plasmin. Plasmin dissolves fibrin clots, enabling bacterial escape and dissemination through host tissues.
The concerted action of these enzymes highlights the complexity of bacterial virulence and reveals promising targets for therapeutic intervention in infectious disease management.
Many pathogenic bacteria produce molecules called virulence factors that help them infect host tissues.
One important group of virulence factors is extracellular enzymes.
For example, Neisseria gonorrhoeae produces IgA proteases.
These enzymes cleave secretory immunoglobulin A on mucosal surfaces, allowing bacteria to adhere to and colonize epithelial cells more effectively.
Streptococcus pyogenes produces hyaluronidase, which breaks down hyaluronic acid in the extracellular matrix.
This loosens the tissue structure, allowing bacteria to spread into deeper tissue layers.
Staphylococcus aureus produces coagulase, an enzyme that converts fibrinogen into fibrin, triggering clot formation around the bacteria. This fibrin barrier conceals bacteria from host immune cells.
S. aureus also produces kinases, such as staphylokinase, which activate host plasminogen to form plasmin. This promotes clot breakdown, allowing the bacteria to spread further in the host.
From Chapter 15:
Now Playing
Clinical Microbiology
34 Views
Clinical Microbiology
210 Views
Clinical Microbiology
217 Views
Clinical Microbiology
32 Views
Clinical Microbiology
170 Views
Clinical Microbiology
293 Views
Clinical Microbiology
129 Views
Clinical Microbiology
117 Views
Clinical Microbiology
77 Views
Clinical Microbiology
221 Views
Clinical Microbiology
182 Views